KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Overview Fund Activity
Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

177 hedge funds and large institutions have $3.73B invested in Karuna Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 67 increasing their positions, 58 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
177
Holders Change
+6
Holders Change %
+3.51%
% of All Funds
2.8%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
25
Increased
67
Reduced
58
Closed
19
Calls
$28.7M
Puts
$14.6M
Net Calls
+$14.1M
Net Calls Change
+$12.5M

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$50.7M
2
State Street
2
State Street
Massachusetts
$130M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$268M
4
CAM
4
Cormorant Asset Management
Massachusetts
$19M
5
Lord, Abbett & Co
5
Lord, Abbett & Co
New Jersey
$46.9M

Top Sellers

1
Federated Hermes
1
Federated Hermes
Pennsylvania
$137K
2
FCM
2
Farallon Capital Management
California
$44.4M
3
FLAM
3
First Light Asset Management
Minnesota
$14.8M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$108M
5
DTC
5
Deep Track Capital
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
RhumbLine Advisers
76
RhumbLine Advisers
Massachusetts
$2.93M +$84.8K +669 +3%
First Manhattan
77
First Manhattan
New York
$2.73M – – –
ACM
78
Altium Capital Management
New York
$2.66M +$2.66M +21,000 New
Legal & General Group
79
Legal & General Group
United Kingdom
$2.64M +$303K +2,388 +13%
JPMorgan Chase & Co
80
JPMorgan Chase & Co
New York
$2.56M +$420K +3,317 +20%
NIP
81
Nicholas Investment Partners
California
$2.56M +$2.56M +20,189 New
MB
82
MPM BioImpact
Massachusetts
$2.54M +$2.54M +20,000 New
CS
83
Credit Suisse
Switzerland
$2.46M +$406K +3,202 +20%
Allianz Asset Management
84
Allianz Asset Management
Germany
$2.4M -$43K -339 -2%
PCM
85
Patient Capital Management
Maryland
$2.26M -$178K -1,400 -7%
New York State Common Retirement Fund
86
New York State Common Retirement Fund
New York
$2.22M +$180K +1,421 +9%
Citadel Advisors
87
Citadel Advisors
Florida
$2.12M +$1.18M +9,313 +126%
EP
88
Eversept Partners
New York
$2.02M – – –
CSS
89
Cubist Systematic Strategies
Connecticut
$2.01M +$529K +4,173 +36%
ECM
90
Endurant Capital Management
California
$1.95M +$1.95M +15,342 New
Wells Fargo
91
Wells Fargo
California
$1.8M -$933K -7,355 -34%
Susquehanna International Group
92
Susquehanna International Group
Pennsylvania
$1.67M -$870K -6,863 -34%
MIM
93
MetLife Investment Management
New Jersey
$1.56M +$545K +4,297 +54%
Invesco
94
Invesco
Georgia
$1.54M +$59.2K +467 +4%
AIG
95
American International Group
New York
$1.4M -$98.3K -775 -7%
SSA
96
Schonfeld Strategic Advisors
New York
$1.32M +$1.32M +10,400 New
Citigroup
97
Citigroup
New York
$1.31M -$7.81M -61,573 -86%
GC
98
Guggenheim Capital
Illinois
$1.28M +$69.6K +549 +6%
Barclays
99
Barclays
United Kingdom
$1.26M -$3.88M -30,619 -76%
DekaBank Deutsche Girozentrale
100
DekaBank Deutsche Girozentrale
Germany
$1.19M +$111K +900 +10%
2 3
4
5 6